← All trials

NCT04838626

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Sep 7, 2021
Primary completion
Feb 24, 2023
Completion date
Feb 24, 2023
First posted
Apr 9, 2021
Last posted
Dec 2, 2021
Enrollment
195
Arms / groups
1 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.